Gapping down
In reaction to earnings/guidance:
In reaction to earnings/guidance:
- FFIN -4.2%, INDB -3.8%
Other news:
- HTZ -11.1% (pulling back after 44% rally in previous session)
- ZVRA -7.1% (files definitive proxy statement and mails letter to stockholders; urges stockholders to defend board independence from majority influence) SMA -5.7% (flips to fully unsecured on its senior credit facility and private placement notes)
- OLN -3.3% (AMMO completes divestiture of Ammunition Manufacturing Assets to Olin Winchester (OLN))
- VCSA -3.1% (Responds to Revised Unsolicited Proposal from Davidson Kempner Capital Management)
- NVDA -3% (Huawei preparing new AI chip for mass shipment to compete with NVDA, according to Reuters)
- ARVN -2.9% (to Present Preclinical Data for PROTAC BCL6 Degrader, ARV-393, at 2025 American Association for Cancer Research (AACR) Annual Meeting)
- VALN -2.5% (provides update on ACIP Recommendation for its chikungunya vaccine IXCHIQ)
- SYNA -2.3% (entered into new Change in Control and Severance Agreements for Executives effective as of April 17)
- LC -2.1% (To acqurie property in San Francisco)
- TRC -2.1% (Value-Creation Strategy For Shareholders update)
- POWW -2.1% (AMMO completes divestiture of Ammunition Manufacturing Assets to Olin Winchester (OLN))
- APO -1.8% (Chairman to resign; CEO to take on Chairman and CEO role)
- X -1.8% (Trump says a deal with Nippon Steel may be part of Japan tariff negotiations, according to Reuters)
- REGN -1.8% (complete response letter for sBLA for the addition of extended dosing intervals (up to every 24 weeks) for EYLEA HD Injection 8 mg across all approved indications)
- PSX -1.5% (Issues Letter to Shareholders)
- SOC -1.3% (confirms court denied the Commission's request for a temporary restraining order)
- MHK -1.2% (entered into a stipulation and agreement of settlement to resolve four related stockholder derivative actions and related demands)
- EW -1.1% (Eight-Year Data Confirm Long-Term Durability of Edwards' RESILIA Tissue)